Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06191198

Communication Bridge 3 Study

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Detailed description

Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for approximately 17 months. Each participant will receive a laptop equipped with the necessary applications and features for the study. Participants will receive up to 10 evaluations and 20 speech therapy sessions with a licensed speech therapist, as well as access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCommunication Bridge™Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
BEHAVIORALEvidence-Based Impairment FocusedEvidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.

Timeline

Start date
2024-08-23
Primary completion
2028-07-15
Completion
2028-07-15
First posted
2024-01-05
Last updated
2025-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06191198. Inclusion in this directory is not an endorsement.